What is PTC Therapeutics's change in AP?

PTC Therapeutics (PTCT) reported change in AP of -$68.71M in Q1 2026.

How has PTC Therapeutics's change in AP changed year-over-year?

PTC Therapeutics's change in AP decreased by 471.4% year-over-year, from $18.5M to -$68.71M.

What is the long-term trend for PTC Therapeutics's change in AP?

Over 2 years (2021 to 2023), PTC Therapeutics's change in AP has grown at a 4.1% compound annual growth rate (CAGR), from $45.66M to $49.43M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

PTC Therapeutics PTCT Change in AP

Change in AP at other companies

BioMarin PharmaceuticalsBMRN

$3.1M+217%

BridgeBio PharmaBBIO

-$7.17M-141%

Arrowhead ResearchARWR

$15.26M+397%

United TherapeuticsUTHR

-$12.7M-388%

ALN

Alnylam PharmaceuticalsALNY

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's change in AP?: PTC Therapeutics (PTCT) reported change in AP of -$68.71M in Q1 2026.
How has PTC Therapeutics's change in AP changed year-over-year?: PTC Therapeutics's change in AP decreased by 471.4% year-over-year, from $18.5M to -$68.71M.
What is the long-term trend for PTC Therapeutics's change in AP?: Over 2 years (2021 to 2023), PTC Therapeutics's change in AP has grown at a 4.1% compound annual growth rate (CAGR), from $45.66M to $49.43M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.